Skip to main content
. 2021 Sep 13;2021(9):omab080. doi: 10.1093/omcr/omab080

Table 2.

Clinical clues in the diagnosis of GBS and colistin-induced neurotoxicity

GBS findings Clinical features shared between GBS and colistin-induced neurotoxicity Colistin-induced neurotoxicity findings
Cytoalbuminologic dissociation Psychiatric adverse effects (e.g. hallucination) [3] Perioral paresthesia
Abnormal electrodiagnostic findings: slowing nerve conduction Predominantly sensory deficits [4]
Bilateral limb weakness
Decreased reflexes
Sensory deficit
Bad taste in mouth